Kate Gee | Signature Litigation
-
Representations and the limits of deceit in M&A transactions
The judgment sends a powerful message about the limits of deceit in heavily negotiated M&A transactions and the high threshold for these types of claims.
-
Third‑party disclosure: a practical guide for pharmaceutical compliance and risk teams
Principal third-party disclosure mechanisms and the common pitfalls for pharmaceutical compliance and risk teams.